These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 14722106)

  • 21. Zinc inhibits osteoclast differentiation by suppression of Ca2+-Calcineurin-NFATc1 signaling pathway.
    Park KH; Park B; Yoon DS; Kwon SH; Shin DM; Lee JW; Lee HG; Shim JH; Park JH; Lee JM
    Cell Commun Signal; 2013 Oct; 11():74. PubMed ID: 24088289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin 29 inhibits RANKL-induced osteoclastogenesis via activation of JNK and STAT, and inhibition of NF-κB and NFATc1.
    Peng Q; Luo A; Zhou Z; Xuan W; Qiu M; Wu Q; Xu L; Kong X; Zhang M; Tan W; Xue M; Wang F
    Cytokine; 2019 Jan; 113():144-154. PubMed ID: 30001863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis.
    Kim K; Kim JH; Lee J; Jin HM; Lee SH; Fisher DE; Kook H; Kim KK; Choi Y; Kim N
    J Biol Chem; 2005 Oct; 280(42):35209-16. PubMed ID: 16109714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation.
    Sundaram K; Nishimura R; Senn J; Youssef RF; London SD; Reddy SV
    Exp Cell Res; 2007 Jan; 313(1):168-78. PubMed ID: 17084841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporin a inhibits calcineurin/nuclear factor of activated T-cells signaling and induces apoptosis in retinoblastoma cells.
    Eckstein LA; Van Quill KR; Bui SK; Uusitalo MS; O'Brien JM
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):782-90. PubMed ID: 15728531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcineurin/NFAT pathway mediates wear particle-induced TNF-α release and osteoclastogenesis from mice bone marrow macrophages in vitro.
    Liu FX; Wu CL; Zhu ZA; Li MQ; Mao YQ; Liu M; Wang XQ; Yu DG; Tang TT
    Acta Pharmacol Sin; 2013 Nov; 34(11):1457-66. PubMed ID: 24056707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcineurin/NFAT signaling pathway mediates titanium particle‑induced inflammation and osteoclast formation by inhibiting RANKL and M‑CSF in vitro.
    Zhang Y; Jiang P; Li W; Liu X; Lu Y; Huang Z; Song K
    Mol Med Rep; 2017 Dec; 16(6):8223-8230. PubMed ID: 28990090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis.
    Youn HD; Chatila TA; Liu JO
    EMBO J; 2000 Aug; 19(16):4323-31. PubMed ID: 10944115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.
    Crotti TN; Flannery M; Walsh NC; Fleming JD; Goldring SR; McHugh KP
    Gene; 2006 May; 372():92-102. PubMed ID: 16513293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulsed electromagnetic field inhibits RANKL-dependent osteoclastic differentiation in RAW264.7 cells through the Ca
    Zhang J; Xu H; Han Z; Chen P; Yu Q; Lei Y; Li Z; Zhao M; Tian J
    Biochem Biophys Res Commun; 2017 Jan; 482(2):289-295. PubMed ID: 27856256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCR1 acts downstream of NFAT2 in osteoclastogenesis and enhances cell migration.
    Ishida N; Hayashi K; Hattori A; Yogo K; Kimura T; Takeya T
    J Bone Miner Res; 2006 Jan; 21(1):48-57. PubMed ID: 16355273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NFAT2 is an essential mediator of orthopedic particle-induced osteoclastogenesis.
    Yamanaka Y; Abu-Amer W; Foglia D; Otero J; Clohisy JC; Abu-Amer Y
    J Orthop Res; 2008 Dec; 26(12):1577-84. PubMed ID: 18655139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos.
    Matsuo K; Galson DL; Zhao C; Peng L; Laplace C; Wang KZ; Bachler MA; Amano H; Aburatani H; Ishikawa H; Wagner EF
    J Biol Chem; 2004 Jun; 279(25):26475-80. PubMed ID: 15073183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanistic insight into osteoclast differentiation in osteoimmunology.
    Takayanagi H
    J Mol Med (Berl); 2005 Mar; 83(3):170-9. PubMed ID: 15776286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
    Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
    J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cot kinase promotes Ca2+ oscillation/calcineurin-independent osteoclastogenesis by stabilizing NFATc1 protein.
    Kuroda Y; Hisatsune C; Mizutani A; Ogawa N; Matsuo K; Mikoshiba K
    Mol Cell Biol; 2012 Jul; 32(14):2954-63. PubMed ID: 22615493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two distinct action mechanisms of immunophilin-ligand complexes for the blockade of T-cell activation.
    Matsuda S; Shibasaki F; Takehana K; Mori H; Nishida E; Koyasu S
    EMBO Rep; 2000 Nov; 1(5):428-34. PubMed ID: 11258483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
    J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.
    Hong G; Zhou L; Shi X; He W; Wang H; Wei Q; Chen P; Qi L; Tickner J; Lin L; Xu J
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB.
    Tsatsanis C; Patriotis C; Tsichlis PN
    Oncogene; 1998 Nov; 17(20):2609-18. PubMed ID: 9840924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.